Association of Obesity and Cardiovascular Outcomes in Atrial Fibrillation
Launched by AJOU UNIVERSITY SCHOOL OF MEDICINE · Dec 2, 2022
Trial Information
Current as of January 16, 2025
Active, not recruiting
Keywords
ClinConnect Summary
This retrospective nationwide cohort study used administrative claims data from the Korean National Health Insurance Service (NHIS) and the combined health check-up database of the National Health Insurance Corporation between 2013 and 2020.
The investigators included oral anticoagulant (OAC) new users diagnosed with atrial fibrillation (AF) between January 2015 and December 2020. Patients aged \<20 years, those who were regarded as valvular AF patients (patients with mitral stenosis or prosthetic heart valve), those with possible alternative indications for OAC (pulmonary embolism, deep v...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Oral anticoagulant (OAC) new users diagnosed with atrial fibrillation (AF) between January 2015 and December 2020
- Exclusion Criteria:
- • Patients aged \<20 years
- • Valvular AF patients
- • Possible alternative indications for OAC (pulmonary embolism, deep vein thrombosis, or recent joint replacement surgery)
- • Cancer patients
Trial Officials
Kwang-No LEE
Principal Investigator
Ajou University School of Medicine
About Ajou University School Of Medicine
Ajou University School of Medicine is a leading academic institution dedicated to advancing medical research and education. Located in South Korea, the School of Medicine is renowned for its commitment to innovative clinical trials that aim to improve patient outcomes and enhance healthcare practices. With a focus on multidisciplinary collaboration, Ajou University fosters a research environment that integrates cutting-edge technologies and scientific inquiry. The institution is dedicated to ethical standards and regulatory compliance, ensuring the safety and welfare of participants in all clinical studies. Through its robust training programs and partnerships, Ajou University School of Medicine aims to contribute significantly to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Suwon, Gyeong Gido, Korea, Republic Of
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials